Viewing Study NCT03924050


Ignite Creation Date: 2025-12-24 @ 5:02 PM
Ignite Modification Date: 2025-12-25 @ 2:42 PM
Study NCT ID: NCT03924050
Status: UNKNOWN
Last Update Posted: 2022-12-27
First Post: 2019-04-18
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Toripalimab Plus Pemetrexed+Platinus in Advanced Non-small-cell Lungcancer Patients Previsouly Treated EGFR-TKI
Sponsor: Shanghai Junshi Bioscience Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module